Inspire Medical downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded Inspire Medical (INSP) to Sector Perform from Outperform with a price target of $90, down from $175. The firm’s Expert checks suggest Inspire V coding headwinds are likely to persist, creating physician disincentive and also putting them at a competitive disadvantage, the analyst tells investors in a research note. While Inspire’s 2026 guidance does not include higher reimbursement, the firm is lowering its 2026 estimates on lower expected utilization.